There are potential share price gains, and then there are potential share price gains. In the view of one analyst, Viking Therapeutics (NASDAQ: VKTX) currently stands in front of the latter variety.

Viking's Valhalla 55 recognized for innovation, in-house design and American-made quality. The post Valhalla 55 Sport Yacht Earns FLIBS Best of Show Award appeared first on Salt Water Sportsman.

Viking Therapeutics, a San Diego developer of metabolic and endocrine disorder therapies, is selling $55 million of its stock in a public offering. The company is selling 11 million shares at $5 each.

Viking has carved a profitable and influential niche in the river cruising business, but the success of parlaying that model has yet to be seen. We're betting the same focus that built its river ...

Viking on Wednesday provided its first earnings report since its IPO earlier this month. The company, which operates 92 luxury river and ocean cruises, gave a broadly upbeat report. Here are some key ...

Take advantage of real dealer pricing and shop special offers on new and used boats. Select your boat to get started. A boat's history affects it's value—check the history of this 2000 Viking Yacht ...

Take advantage of real dealer pricing and shop special offers on new and used boats. Select your boat to get started. A boat's history affects it's value—check the history of this 2013 Viking Yacht ...

Viking Therapeutics, a biotech developing treatments for diabetes and other metabolic and endocrine disorders, announced terms for its IPO on Tuesday. The San Diego, CA-based company plans to raise ...

The biotech is getting a lot of attention for one of its pipeline drugs. VK2735 looks like it has a solid chance at becoming a blockbuster obesity treatment. The reason Viking is getting so much added ...